Previous 10 | Next 10 |
As many readers know, I have covered the MannKind ( MNKD ) story for quite some time. Over the years I have outlined various projections and models with a particular focus on the cash situation and cash flows at MannKind. Subsequent to the termination of the Sanofi ( SNY ) deal, MannKind fou...
Several years ago, Al Mann founded MannKind ( MNKD ) with a vision. Part of that vision was Afrezza. Early investors eagerly supported the concept of his vision. It was easy to buy into. Inhaled insulin vs. needles… "Where do I sign up". Unfortunately, the MannKind story has been a chal...
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2019 Earnings Conference Call August 07, 2019 05:00 PM ET Company Participants Jason Shandell - President Bill Peters - Chief Financial Officer Conference Call Participants David Maris - Wells Fargo Gary Nachman - BMO Capital Market...
MannKind ( MNKD ) reported its Q2 earnings after the bell on Wednesday, August 7th. For the quarter, it reported a net loss of $12.4 million on revenues of $15 million, which included the recognition of $8.9 million from a milestone payment. Overall, there were several improvements made in...
Amphastar Pharmaceuticals (NASDAQ: AMPH ): Q2 Non-GAAP EPS of $0.08 beats by $0.03 ; GAAP EPS of $0.96. More news on: Amphastar Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
RANCHO CUCAMONGA, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended June 30, 2019. Second Quarter Highlights Net revenues of $79.0 milli...
AAOI , AGO , AIG , ALB , AMPH , ANGI , ARNA , ASRT , ATO , AVLR , AZPN , BKNG , BREW , CABO , CAI , CCMP , CDE , CECO , CLI , COLL , CPA , CPRX , CSGS , CTL , CVNA , CWH , DAR , DOX , DVAX , EB , ECPG , ENS , ENV , ET , EVRG , FG , FLO , FNV , FOSL , ...
RANCHO CUCAMONGA, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2019 ended June 30, 2019, after the market closes on Wednesday, August 7, 2019, and will hold a conference cal...
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this Read more ...
RANCHO CUCAMONGA, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President, will be presenting at the BMO Prescriptions for Success Healthcare Conference on Tuesday, June 25, 2019 at 2:40 p.m. Eastern Time, New Y...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
The Federal Trade Commission (FTC) is intensifying its efforts to challenge numerous pharmaceutical patent listings, aiming to facilitate...
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 30, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2024 ended March 31, 2024, after the market closes on Wednesday, May 8, 2024, and will hold a conference call to discuss its...
2024-04-29 08:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...